AI, Quality, and Accountability: Six Questions Every Quality Leader Should Ask  You can delegate the task. You cannot delegate the accountability  Artificial intelligence is becoming an integral part of clinical development, supporting everything from protocol optimization and site selection to data management and medical writing. According to ACRO’s 2026 State of the Industry Report, 71% of participating member companies reported using AI for strategic study feasibility Read more
State of Biopharma R&D 2026: 7 Numbers Every Sponsor Should Know   Biopharma enters the second half of 2026 with no shortage of innovation.  New modalities are advancing.   Emerging biotech is responsible for an increasing share of clinical development.  Artificial intelligence is moving from experimentation into R&D workflows.   And dozens of novel medicines continue to reach patients every year.  Yet the economics and execution of drug development Read more
Clinical Research Focus. 57th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of July 2026. Read more
The Obesity Drug Race: Who Can Challenge Lilly and Novo? Obesity has become one of the biggest opportunities in drug development. By 2035, an estimated 1.53 billion adults globally are projected to be living with obesity. When overweight is included, the number could reach 3.3 billion, or more than half of the world’s adult population. The economic impact could exceed $4 trillion annually. The pharmaceutical Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us